Global Ketorolac Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ketorolac Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.
Ketorolac Injection report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ketorolac Injection market is projected to reach US$ 1125.6 million in 2034, increasing from US$ 939.8 million in 2022, with the CAGR of 2.7% during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ketorolac Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Concentration, Application and Regions Listed in the Report
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Segment by Concentration
15mg/ml
30mg/ml
Hospital
Clinics
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ketorolac Injection market further
Chapter 1Product Definition, Product Concentrations, Volume and Revenue analysis of Each Concentration in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ketorolac Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ketorolac Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ketorolac Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ketorolac Injection introduction, etc. Ketorolac Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Ketorolac Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Ketorolac Injection report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ketorolac Injection market is projected to reach US$ 1125.6 million in 2034, increasing from US$ 939.8 million in 2022, with the CAGR of 2.7% during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ketorolac Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Concentration, Application and Regions Listed in the Report
By Company
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Segment by Concentration
15mg/ml
30mg/ml
Segment by Application
Hospital
Clinics
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ketorolac Injection market further
Chapter 1Product Definition, Product Concentrations, Volume and Revenue analysis of Each Concentration in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ketorolac Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ketorolac Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ketorolac Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ketorolac Injection introduction, etc. Ketorolac Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Ketorolac Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices